This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.

Consumer Law
Misrepresentation
Unfair Competition; Dietary Supplements

The People of the State of California v. Iovate Health Sciences Inc., Iovate Health Sciences USA Inc.

Published: Jan. 28, 2012 | Result Date: Dec. 21, 2011 | Filing Date: Jan. 1, 1900 |

Case number: 26-57870 Settlement –  $1,500,000

Court

Napa Superior


Attorneys

Plaintiff

Daryl A. Roberts

Matthew T. Cheever
(Office of the Sonoma County District Attorney)

Tracy E. Hughes
(Office of the Los Angeles County Counsel)

Robert Nichols

Yen Dang

Diane M. Taira

Erin Dervin

Kelly J. Walker

Scott D. Patton

John F. Hubanks


Defendant

John E. Villafranco
(Kelley, Drye & Warren LLP)

Michele B. Corash
(Morrison & Foerster LLP)


Facts

The district attorney offices in Napa, Alameda, Marin, Monterey, Orange, Santa Clara, Santa Cruz, Shasta, Solano and Sonoma counties, in the name of the People of the State of California, sued Iovate Health Sciences, Inc., a Canadian corporation, and Iovate Health Sciences USA, Inc., its American affiliate. The lawsuit related to the advertising claims defendants made and disseminated while marketing numerous dietary supplement products. Laboratory tests revealed that one of defendants' dietary supplements (Cold MD) contained lead in concentrations exceeding that allowed by Proposition 65.

Contentions

PLAINTIFF'S CONTENTIONS:
Plaintiff alleged that defendants engaged in false and misleading advertising in connection with their dietary supplement products because of defendants' failure to provide competent and reliable scientific evidence to support the advertising claims made for these products. Plaintiff alleged that because of these false and misleading claims, defendants' products were misbranded, in violation of the Sherman Law. Plaintiff also alleged that because of the lead levels in one of these products, defendants violated Proposition 65 for having failed to place proper warnings on them. Lastly, plaintiff alleged that defendants sold new unapproved drugs, in violation of the Sherman Law. All of these activities constituted unfair competition.

Result

Defendants paid $1,200,000 in civil penalties, $250,000 in investigative costs, and $50,000 in cy pres restitution, for a total settlement amount of $1.5 million.


#106275

For reprint rights or to order a copy of your photo:

Email jeremy@reprintpros.com for prices.
Direct dial: 949-702-5390